Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Angell Zhang ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Advertisers Slapped With Infringement Notices For Non-Compliant Advertising Of Therapeutic Goods
Advertisers are reminded the Therapeutic Goods Advertising Code 2018 (TGAC) was recently amended by the Therapeutic Goods Amendment (Therapeutic Goods Advertising Code) Instrument 2019.
Australia
13 Sep 2019
2
The Therapeutic Goods Administration Flexes Its Enforcement Muscles
The TGA has successfully brought a claim against Peptide Clinics Australia Pty Ltd for non-compliance with the new advertising regime which includes higher penalties for therapeutic goods advertising offences.
United States
16 Aug 2019
3
New Therapeutic Goods Advertising Code: What You Need To Know
The Therapeutic Goods Advertising Code (Code) is the latest legislative instrument to be implemented as part of the Australian Government's response ...
Australia
20 Jul 2018
4
How To Submit Advertising Complaints About Therapeutic Goods
As part of the recent advertising reforms, the Therapeutic Goods Administration (TGA) has now become the single agency for therapeutic goods advertising complaints management.
Australia
12 Jul 2018
5
New Therapeutic Goods Legislation: What You Need To Know
The Therapeutic Goods Amendment (2017 Measures No.1) Bill 2017 and the Therapeutic Goods (Charges) Amendment Bill 2017 passed through both Houses on 15 February 2018. The bills have yet to receive Royal Assent.
Australia
2 Mar 2018
6
New Uniform Recall Procedure For Therapeutic Goods
The new version of the Uniform Recall Procedure for Therapeutic Goods (URPTG) was published on 3 October 2017. This version replaces its 2004 predecessor.
Australia
25 Jan 2018
7
Aligns With The European Medical Device Regulatory Framework
In July 2017, the TGA sought comments from interested parties to further align Australian and European medical device regulatory requirements to...
Australia
6 Nov 2017
8
TGA Response: Changes To Accessing Unapproved Therapeutic Goods Through The Authorised Prescriber (AP) And Special Access Schemes (SAS)
Category B patients are those who require the use of unapproved therapeutic goods and do not have a life-threatening condition or illness.
Australia
19 Oct 2017
Links to Result pages
 
1